查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649474

周邊血管介入市場：預測（2025-2030）

Peripheral Vascular Intervention Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計周邊血管介入市場規模將以 5.74% 的複合年成長率成長，從 2025 年的 137.65 億美元增至 2030 年的 181.98 億美元。

周邊血管介入治療（PVI）是一種微創手術，利用靈活的儀器進入心臟外的血管。這些手術可以打通阻塞的血管、清除血栓並控制高血壓。 PVI 是一種先進的方法，可最大限度地減少大切口的需要，從而縮短恢復時間、減少疼痛、降低併發症風險並縮短住院時間。介入性心臟科醫師利用這些尖端治療方法來改善患者的治療效果。周邊血管介入市場正在擴大，主要原因是周邊動脈疾病（PAD）盛行率上升和技術進步。人們對微創手術的偏好日益成長、人口老化以及醫療保健支出的增加進一步推動了這一成長。周邊動脈疾病 (PAD) 限制了手腳的血液流動，並且由於糖尿病、肥胖和吸煙等因素而更加常見。藥物釋放型支架、動脈粥狀硬化斑塊切除術狀硬化切除裝置和栓塞顆粒等創新設備正在改善性能和患者的治療效果。此外，老年人口的增加和醫療支出的增加也直接導致了這些治療的需求。

周邊血管介入市場促進因素：

  • 周邊動脈疾病（PAD）盛行率不斷上升：PAD 發病率不斷上升是推動周邊血管介入市場成長的關鍵因素。當供應血液到四肢的動脈變窄或被斑塊阻塞時，就會發生周邊動脈疾病 (PAD)，引發腿部疼痛和創傷治療不良等症狀。由於不健康的生活方式，周邊動脈疾病 (PAD) 的盛行率不斷上升，從而對標靶治療的需求增加。隨著介入和設備技術的進步，人們已經看到了向血管成形術和支架置入術等微創手術的重大轉變。

預計這一趨勢將繼續增強，並為醫療設備製造商創新新產品創造重大機會。例如，2024年11月，飛利浦在美國招募了首批用於治療周邊動脈疾病 (PAD) 的新型整合設備臨床試驗患者。這種創新設備將雷射切除術和血管內碎石術結合到一個程序中，簡化了工作流程，同時降低了風險並改善了患者的治療效果。

周邊血管介入市場的地理展望：

  • 北美預計將佔據主要市場佔有率：周邊血管介入市場分為北美、南美、歐洲、中東和非洲、亞太地區。由於對可再生能源解決方案的強勁需求和政府促進永續性的獎勵，北美預計將主導這一市場。美國市場尤其強勁，因為不斷上升的肥胖率鼓勵更多的人成為健身房會員並過上更健康的生活。

北美先進的醫療保健基礎設施支援快速採用新的血管技術和治療方法。此外，在美國等已開發國家，先進醫療服務的優惠報銷政策增加了人們獲得醫療服務的機會。周邊動脈疾病 (PAD) 和深層靜脈栓塞症形成病例的增加也推動了對周邊血管介入設備的需求。區域參與者正在投資周邊血管介入設備的技術創新，促進整體市場的成長。例如，2023年7月，Endologix宣布其DETOUR系統已成功用於第一位接受經皮硬膜動脈搭橋術（PTAB）的患者。這種創新方法允許醫生使用通過股靜脈的支架來繞過股淺動脈的病變。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 細分和區域分析，包括收益成長和預測國家
  • 公司概況（策略、產品、財務、主要發展等）

周邊血管介入市場細分如下：

依產品類型

  • 支架
  • 氣球
  • 動脈粥狀硬化斑塊切除術系統
  • 導管
  • 周邊配件
  • 導管導引線
  • 其他

按應用

  • 周邊動脈疾病
  • 深層靜脈栓塞症（DVT）
  • 動脈瘤
  • 靜脈疾病
  • 肺動脈栓塞（PE）
  • 其他

按最終用戶

  • 醫院
  • 門診手術中心
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
  • 台灣
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 政府監管
  • 專利和正在進行的研究
  • 臨床試驗和階段分析
  • 盛行率和發病率分析

第5章周邊血管介入市場（依產品類型）

  • 介紹
  • 支架
  • 氣球
  • 動脈粥狀硬化斑塊切除術系統
  • 導管
  • 周邊配件
    • 導管導引線
  • 其他

第6章 周邊血管介入市場（依應用）

  • 介紹
  • 周邊動脈疾病
  • 深層靜脈栓塞症（DVT）
  • 動脈瘤
  • 靜脈疾病
  • 肺動脈栓塞（PE）
  • 其他

第 7 章 周邊血管介入市場（依最終使用者）

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

8. 周邊血管介入市場（按地區）

  • 介紹
  • 北美洲
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 南美洲
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 歐洲
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 中東和非洲
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家
  • 亞太地區
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 合併、收購、協議和合作
  • 供應商矩陣

第10章 公司簡介

  • Boston Scientific Corporation
  • Abbott Laboratories
  • BD（Becton, Dickinson and Company）
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • BIOTRONIK
  • Medtronic
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Cook Medical
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems
  • Philips
  • TE Connectivity
  • AngioDynamics
簡介目錄
Product Code: KSI061617250

The peripheral vascular intervention market is estimated to grow at a CAGR of 5.74% to reach a market size of US$18.198 billion in 2030 from US$13.765 billion in 2025.

Peripheral vascular interventions (PVI) are minimally invasive treatments that utilize flexible devices to access blood vessels outside the heart. These procedures can open blocked vessels, remove blood clots, and manage high blood pressure. PVI represents a cutting-edge approach that minimizes the need for large incisions, resulting in faster recovery times, reduced pain, lower complication risks, and shorter hospital stays. Interventional cardiologists leverage these advanced treatment devices to enhance patient outcomes.The peripheral vascular intervention market is expanding primarily due to the rising prevalence of peripheral artery disease (PAD) and advancements in technology. This growth is further supported by an increasing preference for minimally invasive procedures, an aging population, and higher healthcare spending. PAD restricts blood flow to the limbs and is becoming more common due to factors like diabetes, obesity, and smoking. Innovative devices such as drug-eluting stents, atherectomy devices, and embolization particles have improved performance and patient outcomes. Additionally, the growing elderly population and increased healthcare expenditure are directly contributing to the demand for these treatments.

Drivers of the Peripheral Vascular Intervention Market:

  • Rising Prevalence of Peripheral Arterial Disease (PAD): The increasing incidence of PAD is a significant factor driving the growth of the peripheral vascular intervention market. PAD occurs when arteries supplying blood to the limbs become narrowed or blocked by plaque, leading to symptoms such as leg pain and poor wound healing. The prevalence of PAD is rising due to unhealthy lifestyles, which in turn increases the demand for targeted treatments. There is a notable shift toward minimally invasive therapies like angioplasty and stenting, along with advancements in interventional techniques and device technologies.

This trend is expected to continue gaining momentum, creating substantial opportunities for medical device manufacturers to innovate new products. For instance, in November 2024, Philips registered its first patient in the U.S. for a clinical trial involving a novel integrated device designed to treat PAD. This innovative device combines laser atherectomy with intravascular lithotripsy into a single procedure, streamlining workflow while reducing risks and improving patient outcomes.

Geographical Outlook of the Peripheral Vascular Intervention Market:

  • North America Anticipated to Hold Significant Market Share: The peripheral vascular intervention market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific regions. North America is expected to dominate this market due to a strong demand for renewable energy solutions and government incentives promoting sustainability. The U.S. market is particularly robust due to rising obesity rates that encourage gym memberships and healthier lifestyles.

The advanced healthcare infrastructure in North America supports rapid adoption of new vascular technologies and treatments. Furthermore, favorable reimbursement policies for advanced healthcare services enhance access in developed economies like the United States. Growing cases of PAD and deep vein thrombosis are also driving demand for peripheral vascular intervention devices.Regional players are investing in innovation within peripheral vascular intervention devices, contributing to overall market growth. For example, in July 2023, Endologix announced that its DETOUR system successfully completed its first patients undergoing Percutaneous Transmural Arterial Bypass (PTAB). This innovative approach allows doctors to bypass lesions in the superficial femoral artery using stents routed through the femoral vein-particularly beneficial for long lesions or patients unsuitable for traditional surgical bypass.In summary, the peripheral vascular intervention market is poised for significant growth driven by rising prevalence of PAD requiring advanced treatment options, increasing adoption of minimally invasive procedures, technological advancements enhancing device performance, and substantial geographical developments-especially within North America-that support this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Peripheral Vascular Intervention Market has been segmented as following:

By Product Type

  • Stents
  • Balloons
  • Atherectomy System
  • Catheters
  • Peripheral Accessories
  • Guidewires
  • Others

By Application

  • Peripheral Artery Disease
  • Deep Vein Thrombosis (DVT)
  • Aneurysms
  • Venous Disease
  • Pulmonary Embolism (PE)
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Government Agencies Regulations
  • 4.6. Patents and Ongoing Research
  • 4.7. Clinical Trials and Phase Analysis
  • 4.8. Prevalence and Incidence Rate Analysis

5. PERIPHERAL VASCULAR INTERVENTION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Stents
  • 5.3. Balloons
  • 5.4. Atherectomy System
  • 5.5. Catheters
  • 5.6. Peripheral Accessories
    • 5.6.1. Guidewires
  • 5.7. Others

6. PERIPHERAL VASCULAR INTERVENTION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Peripheral Artery Disease
  • 6.3. Deep Vein Thrombosis (DVT)
  • 6.4. Aneurysms
  • 6.5. Venous Disease
  • 6.6. Pulmonary Embolism (PE)
  • 6.7. Others

7. PERIPHERAL VASCULAR INTERVENTION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. PERIPHERAL VASCULAR INTERVENTION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.3. Vendor Matrix

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Abbott Laboratories
  • 10.3. BD (Becton, Dickinson and Company)
  • 10.4. Zylox-Tonbridge Medical Technology Co., Ltd.
  • 10.5. BIOTRONIK
  • 10.6. Medtronic
  • 10.7. Terumo Corporation
  • 10.8. B. Braun Melsungen AG
  • 10.9. Cook Medical
  • 10.10. Meril Life Sciences Pvt. Ltd.
  • 10.11. Merit Medical Systems
  • 10.12. Philips
  • 10.13. TE Connectivity
  • 10.14. AngioDynamics